Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Innate Immun. 2013 Oct 9;20(7):697–711. doi: 10.1177/1753425913505122

Table 3.

Cohort II infection data.

All HCT patiens
Allogeneic
Autologous/Syngeneic
Patients with infections (n/total) (%) (n/total) (%) (n/total) (%)
Bacteria only 45/188 24% 25/134 19% 20/54 37%
Bacteria total 77/188 41% 56/134 43% 21/54 39%
Virus only 9/188 5% 9/134 7% 0/54 0%
Virus total 40/188 21% 39/134 29% 1/54 2%
Fungal only 0/188 0% 0/134 0% 0/54 0%
Fungal total 6/188 3% 5/134 4% 1/54 2%
Protozoan only 0/188 0% 0/134 0% 0/54 0%
Protozoan total 2/188 1% 2/134 1% 0/54 0%
Multiple types of infection 32/188 17% 31/134 23% 1/54 2%
Total infections 86/188 46% 65/134 49% 21/54 39%